share_log

Riot Platforms | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Riot Platforms, Inc.(14.9%)

Riot Platforms | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Riot Platforms, Inc.(14.9%)

Riot Platforms | SC 13D/A:超過5%持股股東披露文件(修正)-Riot Platforms, Inc.(14.9%)
美股sec公告 ·  06/24 09:00
Moomoo AI 已提取核心訊息
Riot Platforms, Inc., a Nevada-based corporation, has filed an amendment to its Schedule 13D, reporting a significant ownership stake in Bitfarms Ltd., a Canadian company. The amendment, dated June 24, 2024, indicates that Riot Platforms now owns approximately 14.9% of Bitfarms' common shares, with an aggregate purchase price of $132,162,323, funded from Riot's working capital. On the same date, Riot Platforms issued a Requisition Letter to Bitfarms' board of directors, requesting a special meeting of shareholders to elect new independent board members. Additionally, Riot Platforms has withdrawn its previous proposal to acquire Bitfarms at $2.30 per share and is seeking to cease-trade the shareholder rights plan, commonly referred to as a 'Poison Pill', adopted by Bitfarms on June 10, 2024. Riot Platforms has also announced its intention to engage with the reconstituted board regarding a potential business combination.
Riot Platforms, Inc., a Nevada-based corporation, has filed an amendment to its Schedule 13D, reporting a significant ownership stake in Bitfarms Ltd., a Canadian company. The amendment, dated June 24, 2024, indicates that Riot Platforms now owns approximately 14.9% of Bitfarms' common shares, with an aggregate purchase price of $132,162,323, funded from Riot's working capital. On the same date, Riot Platforms issued a Requisition Letter to Bitfarms' board of directors, requesting a special meeting of shareholders to elect new independent board members. Additionally, Riot Platforms has withdrawn its previous proposal to acquire Bitfarms at $2.30 per share and is seeking to cease-trade the shareholder rights plan, commonly referred to as a 'Poison Pill', adopted by Bitfarms on June 10, 2024. Riot Platforms has also announced its intention to engage with the reconstituted board regarding a potential business combination.
總部位於內華達州的Riot Platforms公司已經向加拿大的Bitfarms Ltd.提交了13D表格的修正案,報告其在該公司持有重要股權。該修正案於2024年6月24日提交,表明Riot Platforms現在持有Bitfarms普通股的約14.9%,總購買價格爲1.32162323億美元,資金來源於Riot的營運資本。在同一日期,Riot Platforms向Bitfarms董事會發出征求函,要求召開特別股東大會選舉新的獨立董事會成員。此外,Riot Platforms已經撤回了先前以每股2.30美元的價格收購Bitfarms的提案,並尋求停止交易股東權利計劃,通稱“毒藥丸”,該計劃由Bitfarms於2024年6月10日通過。 Riot Platforms還宣佈其意圖與重組後的董事會就潛在的業務合併進行交流。
總部位於內華達州的Riot Platforms公司已經向加拿大的Bitfarms Ltd.提交了13D表格的修正案,報告其在該公司持有重要股權。該修正案於2024年6月24日提交,表明Riot Platforms現在持有Bitfarms普通股的約14.9%,總購買價格爲1.32162323億美元,資金來源於Riot的營運資本。在同一日期,Riot Platforms向Bitfarms董事會發出征求函,要求召開特別股東大會選舉新的獨立董事會成員。此外,Riot Platforms已經撤回了先前以每股2.30美元的價格收購Bitfarms的提案,並尋求停止交易股東權利計劃,通稱“毒藥丸”,該計劃由Bitfarms於2024年6月10日通過。 Riot Platforms還宣佈其意圖與重組後的董事會就潛在的業務合併進行交流。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息